Al-Mustaqbal Journal of Pharmaceutical and Medical Sciences(MJPMS) is a reputable scholarly publication committed to advancing knowledge in the fields of pharmaceutical and medical sciences through its double-blind peer review process. The journal exclusively accepts articles in English, reflecting its commitment to fostering global communication within the scientific community.

Since its inaugural issue in December 2023, the journal has functioned as an open-access publication. MJPMS ensures that its valuable content is freely accessible to researchers, scholars, and enthusiasts alike. With a triannual publication frequency, the journal maintains a timely dissemination of cutting-edge research in pharmaceutical and medical sciences.

MJPMS welcomes a variety of contributions, including Original Research, Review Articles (literature reviews, systematic reviews, meta-analyses) and Case Reports/Case Studies, broadening the spectrum of valuable insights for its readership. Notably, the journal distinguishes itself with an efficient review and publication process. Editorial screening is completed within 1–2 weeks, peer review within 4–6 weeks, with a first decision provided within 8 weeks of submission and publication within 4–8 weeks after acceptance.

See the Aims and Scope for a complete coverage of the journal.